Mariana Rocha Selected Research

GMP Reductase

1/2020

Identification of a novel heterozygous guanosine monophosphate reductase (GMPR) variant in a patient with a late-onset disorder of mitochondrial DNA maintenance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariana Rocha Research Topics

Disease

1	Thrombocytopenia (Thrombopenia) 01/2022
1	Stroke (Strokes) 08/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Late Onset Disorders 01/2020
1	Paresis (Hemiparesis) 01/2020
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2020
1	Renal Insufficiency (Renal Failure) 04/2019
1	Breast Neoplasms (Breast Cancer) 04/2019
1	Edema (Dropsy) 04/2019
1	Hydronephrosis 04/2019
1	Neoplasm Metastasis (Metastasis) 04/2019
1	Neoplasms (Cancer) 01/2018
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2018
1	Anemia 01/2018

Drug/Important Bio-Agent (IBA)

1	VaccinesIBA 01/2022
1	GMP ReductaseIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Anastrozole (Arimidex)FDA LinkGeneric 04/2019
1	CreatinineIBA 04/2019
1	Transferrin (beta 2 Transferrin)IBA 01/2018
1	IronIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Ferritins (Ferritin)IBA 01/2018
1	ferric carboxymaltoseIBA 01/2018

Therapy/Procedure

1	Thrombectomy 08/2020
1	Adjuvant Chemotherapy 01/2018
1	Drug Therapy (Chemotherapy) 01/2018